Effects of circulating IGF-I on glucose and amino acid kinetics in the ovine fetus

Edward A. Liechty, David Boyle, Helen Moorehead, Wei Hua Lee, Ronald R. Bowsher, Scott Denne

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

To investigate the role of insulin-like growth factor I (IGF-I) in the regulation of fetal metabolism, the kinetics of leucine, phenylalanine, and glucose were assessed in the chronically catheterized ovine fetus (0.85 gestation) before and during infusion of recombinant human IGF-I (rhIGF-I). Substrate kinetics were determined by tracer dilution. rhIGF-I was infused at 6.7 nmol · kg fetus-1 h-1. Fetal insulin and growth hormone concentrations were significantly decreased by 50% during rhIGF-I infusion. Net umbilical glucose uptake was unchanged, and glucose rate of appearance increased in the fed state only. There were no changes in the net umbilical uptakes of leucine or phenylalanine, but the rates of appearance of both declined during rhIGF-I infusion, indicative of decreased fetal protein breakdown (R(a,Leu) 45.4 ± 1.40 to 40 ± 1.4 μmol/min in the fed state, 43 ± 1.5 to 37 ± 1.5 μmol/min in the fasted state; R(a,Phe) 10.7 ± 0.3 to 10.4 ± 0.3 μmol/min in the fed state and from 10.7 ± 0.3 to 9.8 ± 0.3 μmol/min in the fasted state). Leucine oxidation was also decreased (8.90 ± 0.76 to 6.52 ± 0.81 μmol/min, P = 0.025), more so in the fasted than the fed state. These results indicate a significant antiproteolytic endocrine effect for IGF-I in the late-gestation mammalian fetus.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume271
Issue number1 34-1
StatePublished - Jul 1996
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor I
Sheep
Fetus
Amino Acids
Glucose
Kinetics
Leucine
Umbilicus
Phenylalanine
Fetal Proteins
Pregnancy
Enzyme kinetics
Fetal Development
Metabolism
Growth Hormone
Dilution
Insulin
Oxidation
Substrates

Keywords

  • growth hormone
  • insulin
  • insulin-like growth factor I
  • leucine
  • phenylalanine
  • somatostatin

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

Effects of circulating IGF-I on glucose and amino acid kinetics in the ovine fetus. / Liechty, Edward A.; Boyle, David; Moorehead, Helen; Lee, Wei Hua; Bowsher, Ronald R.; Denne, Scott.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 271, No. 1 34-1, 07.1996.

Research output: Contribution to journalArticle

@article{9b42d8a1e8ae42af886293f133bb149b,
title = "Effects of circulating IGF-I on glucose and amino acid kinetics in the ovine fetus",
abstract = "To investigate the role of insulin-like growth factor I (IGF-I) in the regulation of fetal metabolism, the kinetics of leucine, phenylalanine, and glucose were assessed in the chronically catheterized ovine fetus (0.85 gestation) before and during infusion of recombinant human IGF-I (rhIGF-I). Substrate kinetics were determined by tracer dilution. rhIGF-I was infused at 6.7 nmol · kg fetus-1 h-1. Fetal insulin and growth hormone concentrations were significantly decreased by 50{\%} during rhIGF-I infusion. Net umbilical glucose uptake was unchanged, and glucose rate of appearance increased in the fed state only. There were no changes in the net umbilical uptakes of leucine or phenylalanine, but the rates of appearance of both declined during rhIGF-I infusion, indicative of decreased fetal protein breakdown (R(a,Leu) 45.4 ± 1.40 to 40 ± 1.4 μmol/min in the fed state, 43 ± 1.5 to 37 ± 1.5 μmol/min in the fasted state; R(a,Phe) 10.7 ± 0.3 to 10.4 ± 0.3 μmol/min in the fed state and from 10.7 ± 0.3 to 9.8 ± 0.3 μmol/min in the fasted state). Leucine oxidation was also decreased (8.90 ± 0.76 to 6.52 ± 0.81 μmol/min, P = 0.025), more so in the fasted than the fed state. These results indicate a significant antiproteolytic endocrine effect for IGF-I in the late-gestation mammalian fetus.",
keywords = "growth hormone, insulin, insulin-like growth factor I, leucine, phenylalanine, somatostatin",
author = "Liechty, {Edward A.} and David Boyle and Helen Moorehead and Lee, {Wei Hua} and Bowsher, {Ronald R.} and Scott Denne",
year = "1996",
month = "7",
language = "English",
volume = "271",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "1 34-1",

}

TY - JOUR

T1 - Effects of circulating IGF-I on glucose and amino acid kinetics in the ovine fetus

AU - Liechty, Edward A.

AU - Boyle, David

AU - Moorehead, Helen

AU - Lee, Wei Hua

AU - Bowsher, Ronald R.

AU - Denne, Scott

PY - 1996/7

Y1 - 1996/7

N2 - To investigate the role of insulin-like growth factor I (IGF-I) in the regulation of fetal metabolism, the kinetics of leucine, phenylalanine, and glucose were assessed in the chronically catheterized ovine fetus (0.85 gestation) before and during infusion of recombinant human IGF-I (rhIGF-I). Substrate kinetics were determined by tracer dilution. rhIGF-I was infused at 6.7 nmol · kg fetus-1 h-1. Fetal insulin and growth hormone concentrations were significantly decreased by 50% during rhIGF-I infusion. Net umbilical glucose uptake was unchanged, and glucose rate of appearance increased in the fed state only. There were no changes in the net umbilical uptakes of leucine or phenylalanine, but the rates of appearance of both declined during rhIGF-I infusion, indicative of decreased fetal protein breakdown (R(a,Leu) 45.4 ± 1.40 to 40 ± 1.4 μmol/min in the fed state, 43 ± 1.5 to 37 ± 1.5 μmol/min in the fasted state; R(a,Phe) 10.7 ± 0.3 to 10.4 ± 0.3 μmol/min in the fed state and from 10.7 ± 0.3 to 9.8 ± 0.3 μmol/min in the fasted state). Leucine oxidation was also decreased (8.90 ± 0.76 to 6.52 ± 0.81 μmol/min, P = 0.025), more so in the fasted than the fed state. These results indicate a significant antiproteolytic endocrine effect for IGF-I in the late-gestation mammalian fetus.

AB - To investigate the role of insulin-like growth factor I (IGF-I) in the regulation of fetal metabolism, the kinetics of leucine, phenylalanine, and glucose were assessed in the chronically catheterized ovine fetus (0.85 gestation) before and during infusion of recombinant human IGF-I (rhIGF-I). Substrate kinetics were determined by tracer dilution. rhIGF-I was infused at 6.7 nmol · kg fetus-1 h-1. Fetal insulin and growth hormone concentrations were significantly decreased by 50% during rhIGF-I infusion. Net umbilical glucose uptake was unchanged, and glucose rate of appearance increased in the fed state only. There were no changes in the net umbilical uptakes of leucine or phenylalanine, but the rates of appearance of both declined during rhIGF-I infusion, indicative of decreased fetal protein breakdown (R(a,Leu) 45.4 ± 1.40 to 40 ± 1.4 μmol/min in the fed state, 43 ± 1.5 to 37 ± 1.5 μmol/min in the fasted state; R(a,Phe) 10.7 ± 0.3 to 10.4 ± 0.3 μmol/min in the fed state and from 10.7 ± 0.3 to 9.8 ± 0.3 μmol/min in the fasted state). Leucine oxidation was also decreased (8.90 ± 0.76 to 6.52 ± 0.81 μmol/min, P = 0.025), more so in the fasted than the fed state. These results indicate a significant antiproteolytic endocrine effect for IGF-I in the late-gestation mammalian fetus.

KW - growth hormone

KW - insulin

KW - insulin-like growth factor I

KW - leucine

KW - phenylalanine

KW - somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0029787883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029787883&partnerID=8YFLogxK

M3 - Article

C2 - 8760095

AN - SCOPUS:0029787883

VL - 271

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 1 34-1

ER -